Increase in proinflammatory cytokines in peripheral blood without haemostatic changes after LPS inhalation

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages 584-587

  Fouassier, Marc ^a   Souweine, Bertrand ^b   Sapin, Anne Françoise ^b   Hashemzadeh, Afshin ^b   Marquès Verdier, Alain ^b   Caillaud, Denis ^b  

^a HÔTEL DIEU   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Cytokines; Fibrinolysis; Haemostasis; Inflammation; Lipopolysaccharide; Lung

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; HYDROCORTISONE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROVOCATION TEST;

ADMINISTRATION, INHALATION; ADULT; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HEMOSTASIS; HUMANS; HYDROCORTISONE; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MALE; PNEUMONIA; YOUNG ADULT;

EID: 70349977161     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.06.014     Document Type: Article

References (36)

1. Levi M., Schultz M.J., Rijneveld A.W., and van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 31 (2003) S238-S242
2. Prabhakaran P., Ware L.B., White K.E., Cross M.T., Matthay M.A., and Olman M.A. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285 (2003) L20-L28
3. Piantadosi C.A., and Schwartz D.A. The Acute Respiratory Distress Syndrome. Ann Intern Med 141 (2004) 460-470
4. Choi G., Schultz M.J., van Till J.W., Bresser P., van der Zee J.S., Boermeester M.A., et al. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J 24 (2004) 786-789
5. Idell S. Coagulation, fibrinolysis and fibrin deposition in acute lung injury. Crit Care Med 31 (2003) S213-S220
6. Günther A., Mosavi P., Heinemann S., Ruppert C., Muth H., Markart P., et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161 (2000) 454-462
7. Schultz M.J., Millo J., Levi M., Hack C.E., Weverling G.J., Garrard C.S., et al. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59 (2004) 130-135
8. Schultz M.J., Haitsma J.J., Zhang H., and Slutsky A.S. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia-a review. Crit Care Med 34 (2006) 871-877
9. Levi M., ten Cate H., van der Poll T., and van Deventer S.J. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270 (1993) 975-979
10. van Deventer S.J., Büller H.R., ten Cate J.W., Aarden L.A., Hack C.E., and Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76 (1990) 2520-2526
11. van der Poll T., and Lowry S.F. Biological responses to endotoxin in humans. In: Tellado J.M., Forse R.A., and Solomkin J.S. (Eds). Modulation of the Inflammatory Response in Severe Sepsis (1995), Karge, Basel, Switzerland 18-32
12. Franco R.F., de Jonge E., Dekkers P.E., Timmerman J.J., Spek C.A., van Deventer S.J., et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 96 (2000) 554-559
13. Jagielo P.J., Thorne P.S., Watt J.L., Frees K.L., Quinn T.J., and Schwartz D.A. Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest 110 (Jul 1996) 263-270
14. Maris N.A., de Vos A.F., Bresser P., van der Zee J.S., Meijers J.C., Lijnen H.R., et al. Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 93 (2005) 1036-1040
15. Angleton P., Chandler W.L., and Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 79 (1989) 101-106
16. Kurnick P.B. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 91 (1995) 1341-1346
17. Liddle G.W. analysis of circadian rhythms in human adrenocortical secretory activity. Arch Intern Med 117 (1966) 739-743
18. Wygrecka M., Markart P., Ruppert C., Kuchenbuch T., Fink L., Bohle R.M., et al. Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application. Thromb Haemost 92 (2004) 529-540
19. Savov J.D., Brass D.M., Berman K.G., McElvania E., and Schwartz D.A. Fibrinolysis in LPS-induced chronic airway disease. Am J Physiol Lung Cell Mol Physiol 285 (2003) L940-L948
20. Miller D.L., Welty-Wolf K., Carraway M.S., Ezban M., Ghio A., Suliman H., et al. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 26 (2002) 650-658
21. Thorn J. The inflammatory response in humans after inhalation of bacterial endotoxin: a review. Inflamm Res 50 (2001) 254-261
22. van der Poll T., Levi M., Hack C.E., ten Cate H., van Deventer S.J., Eerenberg A.J., de Groot E.R., Jansen J., Gallati H., Büller H.R., et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179 (1994) 1253-1259
23. Stouthard J.M., Levi M., Hack C.E., Veenhof C.H., Romijn H.A., Sauerwein H.P., et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 76 (1996) 738-742
24. Bisoendial R.J., Kastelein J.J., Levels J.H., Zwaginga J.J., van den Bogaard B., Reitsma P.H., et al. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 96 (2005) 714-716
25. Kerr R. Interleukin 6 and Haemostasis. Brit J Haematol 115 (2001) 3-12
26. Shing U., Devaraj S., and Jialal I. C-reactive protein decreases tissue plasminogen acyivator activity in human aortic endothelial cells. Evidence that C-reactive protein is procoagulant. Arterioscler Thromb Vasc Biol 25 (2005) 2216-2221
27. Fukumoto S., Allan E.H., Zeheb B., Gelehrterv T.D., and Martin T.J. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts. Endocrinology 130 (1992) 797-804
28. Oikarinen A., Hoyhtya M., and Jarvinen M. Dexamethasone induced plasminogen activator inhibitor: characterization, purification, and preparation of monoclonal antibodies. Arch Dermatol Res 282 (1990) 153-158
29. Devaraj S., Xu D.Y., and Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the mrtabolic syndrome and atherothrombosis. Circulation 107 (2003) 398-404
30. Rega G., Kaun C., Weiss T.W., Demyanets S., Zorn G., Kastl S.P., et al. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue. Circulation 111 (2005) 1938-1945
31. Herbert J.M., Savi P., Laplace M.C., Lalé A., Dol F., Dumas A., et al. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 328 (1993) 268-270
32. Colucci M., Balconi G., Lorenzet R., Pietra A., Locati D., Donati M.B., et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71 (Jun 1983) 1893-1896
33. Colucci M., Paramo J.A., and Collen D. Generation in plasma of a fast acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 75 (1985) 818-824
34. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
35. Orthner C.L., Rodgers G.M., and Fitzgerald L.A. Pyrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: Evidence implicating factor-kappa B in TF induction by diverse agonists. Blood 86 (1995) 436-443
36. Levi M., van der Poll T., and Büller H.R. Bidirectional Relation Between Inflammation and Coagulation. Circulation 109 (2004) 2698-2704